ZA728251B - Composition for the treatment of hyperlipoproteinaemia - Google Patents

Composition for the treatment of hyperlipoproteinaemia

Info

Publication number
ZA728251B
ZA728251B ZA728251A ZA728251A ZA728251B ZA 728251 B ZA728251 B ZA 728251B ZA 728251 A ZA728251 A ZA 728251A ZA 728251 A ZA728251 A ZA 728251A ZA 728251 B ZA728251 B ZA 728251B
Authority
ZA
South Africa
Prior art keywords
hyperlipoproteinaemia
treatment
composition
Prior art date
Application number
ZA728251A
Other languages
English (en)
Inventor
Z Simane
H Nowak
K Irmscher
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA728251B publication Critical patent/ZA728251B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA728251A 1971-12-11 1972-11-21 Composition for the treatment of hyperlipoproteinaemia ZA728251B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161588A DE2161588C3 (de) 1971-12-11 1971-12-11 Mittel zur Behandlung von Hyperlipoproteinämien

Publications (1)

Publication Number Publication Date
ZA728251B true ZA728251B (en) 1973-07-25

Family

ID=5827712

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA728251A ZA728251B (en) 1971-12-11 1972-11-21 Composition for the treatment of hyperlipoproteinaemia

Country Status (14)

Country Link
AT (1) AT327373B (xx)
AU (1) AU466300B2 (xx)
BE (1) BE792421A (xx)
BR (1) BR7208624D0 (xx)
CA (1) CA989307A (xx)
DD (1) DD102583A5 (xx)
DE (1) DE2161588C3 (xx)
FR (1) FR2162493B1 (xx)
GB (1) GB1356094A (xx)
HU (1) HU167337B (xx)
IL (1) IL40912A (xx)
MY (1) MY7700129A (xx)
NL (1) NL159579B (xx)
ZA (1) ZA728251B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502678C3 (de) * 1975-01-23 1981-05-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien
DE2621873C3 (de) 1976-05-17 1981-05-07 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung von Hypercholesterinämien
FR2430229A1 (fr) * 1978-01-16 1980-02-01 Laruelle Claude Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation
US4820739A (en) * 1982-06-28 1989-04-11 Lucta, S.A. Fat suppressant
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions

Also Published As

Publication number Publication date
DE2161588A1 (de) 1973-06-20
DE2161588B2 (de) 1976-05-26
HU167337B (xx) 1975-09-27
IL40912A0 (en) 1973-01-30
CA989307A (en) 1976-05-18
DD102583A5 (xx) 1973-12-20
BR7208624D0 (pt) 1973-09-20
DE2161588C3 (de) 1980-02-14
FR2162493A1 (xx) 1973-07-20
AU4991872A (en) 1974-06-13
NL159579B (nl) 1979-03-15
AU466300B2 (en) 1975-10-23
GB1356094A (en) 1974-06-12
FR2162493B1 (xx) 1975-06-20
BE792421A (fr) 1973-06-07
IL40912A (en) 1975-11-25
ATA1049172A (de) 1975-04-15
MY7700129A (en) 1977-12-31
AT327373B (de) 1976-01-26
NL7216788A (xx) 1973-06-13

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
ZA727741B (en) Thermofomable compositions
ZA727226B (en) Developer composition
ZA722506B (en) Tetrachlorophthalide compounds
JPS52151636A (en) Composition for sensitizing treatment
IE35991L (en) Camphor-containing pharmaceutical composition
ZA723241B (en) Plaster composition
GB1393014A (en) Polyurethane-tar compositions
GB1366395A (en) Coke
ZA727738B (en) Process for the preparation of 4-chloro-2-dimethoxy-aniline
CH609065A5 (en) Process for the preparation of 21-adamantoyloxysteroids
ZA728251B (en) Composition for the treatment of hyperlipoproteinaemia
ZA726255B (en) New composition of matter
GB1370904A (en) Pharmaceutical composition
IL40533A0 (en) The preparation of benzylpyrimidine
IL40762A (en) Process for the preparation of methylcobalamine
IL39848A0 (en) Igniter composition
AU4775472A (en) New polyepoxide-polysiloxane compounds
GB1367202A (en) Reflex-reflecting compositions
ZA717402B (en) Process for the preparation of argininemalate
ZA721363B (en) Pharmaceutical composition
CY755A (en) Therapeutic composition
ZA723908B (en) Desensitizer composition
ZA726400B (en) Process for the preparation of dea-steroids